NASDAQ:HCM

Hutchison China Meditech Adr (sponsored) Stock Forecast

etoro logo Buy HCM
*Your capital is at risk
$11.07
+0.0900 (+0.82%)
At Close: Jul 10, 2026
AI Analysis AI Analysis of HCM AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add HCM to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Hutchison China Meditech Ltd ADR stock upgraded to Hold/Accumulate
(Updated on Jul 10, 2026)

Hold candidate since Jul 10, 2026

The Hutchison China Meditech Ltd ADR stock price gained 0.82% on the last trading day (Friday, 10th Jul 2026), rising from $10.98 to $11.07. During the last trading day the stock fluctuated 0.769% from a day low at $11.05 to a day high of $11.14. The price has risen in 7 of the last 10 days and is up by 7.58% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 15 thousand more shares were traded than the day before. In total, 37 thousand shares were bought and sold for approximately $413.13 thousand.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $11.32 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -30.50% during the next 3 months and, with a 90% probability hold a price between $6.21 and $7.87 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

HCM Signals & Forecast

The Hutchison China Meditech Ltd ADR stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $11.16. On a fall, the stock will find some support from the long-term average at approximately $10.99. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Monday, June 22, 2026, and so far it has risen 10.81%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Hutchison China Meditech Ltd ADR has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.

Support, Risk & Stop-loss for Hutchison China Meditech Ltd ADR stock

Hutchison China Meditech Ltd ADR finds support from accumulated volume at $10.87 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0850 between high and low, or 0.769%. For the last week, the stock has had daily average volatility of 1.95%.

Our recommended stop-loss: $10.60 (-4.23%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 13 days ago.)

Trading Expectations (HCM) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect Hutchison China Meditech Ltd ADR (Sponsored) to open at $11.09, and during the day (based on 14 day Average True Range), to move between $10.90 and $11.24, which gives a possible trading interval of +/-$0.345 (+/-3.17%) up or down from last closing price. If Hutchison China Meditech Ltd ADR (Sponsored) takes out the full calculated possible swing range there will be an estimated 3.17% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $10.87 (1.81%) than the resistance at $11.40 (2.98%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Hutchison China Meditech Ltd ADR (Sponsored) stock A Buy?

Hutchison China Meditech Ltd ADR holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.705 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $11.09 ( 0.136%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

HCM Performance

Trading levels for HCM

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 11.17 0.90%
R2 11.14 0.610%
R1 11.12 0.429%
Price 11.07
S1 11.05 -0.158%
S2 11.03 -0.339%
S3 11.00 -0.632%

Accumulated Volume Support & Resistance Levels

Level Price
R3 11.52 4.07%
R2 11.44 3.34%
R1 11.40 2.98%
Price 11.07
S1 10.87 -1.81%
S2 10.78 -2.62%
S3 10.76 -2.80%

FAQ

What is the symbol for Hutchison China Meditech Ltd ADR (Sponsored) Stock and on which exchange is it traded?
The symbol for Hutchison China Meditech Ltd ADR (Sponsored) is HCM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Hutchison China Meditech Ltd ADR (Sponsored) Stock?
Hutchison China Meditech Ltd ADR holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

How to buy Hutchison China Meditech Ltd ADR (Sponsored) Stock?
Hutchison China Meditech Ltd ADR (Sponsored) Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Hutchison China Meditech Ltd ADR (Sponsored) Stock.

What's the current price of Hutchison China Meditech Ltd ADR (Sponsored) Stock?
As of the end of day on the Jul 10, 2026, the price of an Hutchison China Meditech Ltd ADR (Sponsored) (HCM) share was $11.07.

What is the 52-week high and low for Hutchison China Meditech Ltd ADR (Sponsored) Stock?
The 52-week high for Hutchison China Meditech Ltd ADR (Sponsored) Stock is $19.25 and the 52-week low is $9.77.

What is the market capitalization of Hutchison China Meditech Ltd ADR (Sponsored) Stock?
As of the Jul 10, 2026, the market capitalization of Hutchison China Meditech Ltd ADR (Sponsored) is 1.931B.

When is the next earnings date for Hutchison China Meditech Ltd ADR (Sponsored)?
The upcoming earnings date for Hutchison China Meditech Ltd ADR (Sponsored) is Jul 30, 2026.
Click to get the best stock tips daily for free!
ABOUT HUTCHISON CHINA MEDITECH LTD ADR (SPONSORED)
Hutchison China Meditech ADR (Sponsored)
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for ...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE